Article
ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover <i>in vitro</i> -enriched cell types
2024-10-18
Abstract excerpt
Patient-derived organoids (PDOs) offer new opportunities to model various cancers. However, their application in prostate cancer (PCa) has been hampered by poor success rates and overgrowth of cell types which are not representative of the patient samples. By exploiting a cohort of 164 PCa patient samples and tuning several culture parameters, we show that an extracellular matrix-free (ECM)-free culture system inc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1410b883-6ed7-5f65-af29-18f1b941061c
- DOI
- 10.1101/2024.10.16.618617
